Evidence map›Paper›PMID 39658720›Full record

ArticleAnnals of surgical oncology2025

Commission on Cancer Center Performance with the New Breast Cancer Quality Measures: A Review of Historical Data.

Marie L Fefferman, Danielle M Thompson, Lee G Wilke, Shelley Hwang, Richard Bleicher, Laura M Freedman, Jane L Meisel, Kristine Kuchta, Katharine Yao

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marie L FeffermanDepartment of Surgery, Endeavor Health, Evanston, IL, USA.
Danielle M ThompsonDepartment of Surgery, Endeavor Health, Evanston, IL, USA.
Lee G WilkeDepartment of Surgery, University of Wisconsin-Madison, Madison, WI, USA.
Shelley HwangDepartment of Surgery, Duke University, Durham, NC, USA.
Richard BleicherDepartment of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
Laura M FreedmanDepartment of Radiation Oncology, University of Miami, Coral Gables, FL, USA.
Jane L MeiselDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.
Kristine KuchtaDepartment of Surgery, Endeavor Health, Evanston, IL, USA.
Katharine YaoDepartment of Surgery, Endeavor Health, Evanston, IL, USA. kyao@northshore.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince 2022, the Commission on Cancer (CoC) has developed three new breast cancer quality measures (QMs): time to surgery (BCSdx) and radiation (BCSRT) and the use of neoadjuvant therapy for triple negative and HER2/neu positive breast cancer (BneoCT). This study assesses CoC center historical performance for these measures and facility factors associated with low performance.

methodsWe examined the median number of days for time to surgery and radiation, and the proportion of facilities that achieved an estimated performance rate (EPR) of 70%, 80%, and 90% from 2004 to 2020 for all three measures. Multivariable logistic regression analysis was used to determine the association between facility factors and not achieving 80% EPR for all three measures.

resultsThe median number of days to surgery and radiation in 2004 were 16 and 43, respectively, compared with 34 and 48 in 2020 (p < 0.01). For BneoCT, BCSdx, and BCSRT measures, the proportion of facilities that attained ≥ 80% EPR was 68.5%, 72.2%, and 35.2%, respectively. The proportion of facilities that attained ≥ 80% EPR in 2004 was 92.3% for BCSdx and 49.8% for BCSRT compared with 69.6% and 39.4%, respectively, in 2020. BneoCT performance improved over time. Academic facilities and facilities serving a larger proportion of socioeconomically disadvantaged patients were approximately twice as likely to be unable to achieve compliance with all three QMs.

conclusionsPerformance levels for BCSRT are the lowest of all three measures. Academic centers and centers with a higher proportion of Medicaid patients are more likely to have lower adherence with all three QMs.

Indexed as

Breast NeoplasmsCancer Care FacilitiesQuality Indicators, Health CareTime-to-TreatmentFemaleHumansMastectomyNeoadjuvant TherapyPrognosisUnited StatesBreast neoplasmsBreast quality measuresNational Cancer DatabaseNeoadjuvant chemotherapyRadiation therapySurgeryTime to treatment

Identifiers

PMID39658720

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.